Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) chief executive Ajan Reginald speaks to Proactive's Thomas Warner after announcing the biotech company has developed a new platform of potential anti-cancer messenger RNA (mRNA) therapeutics.
Reginald reveals the reasons for the move, saying that "developing cutting edge medicines using innovative new approaches" is "what Roquefort is all about."